IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moreira, A. L.
Right arrow Articles by Kaplan, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moreira, A. L.
Right arrow Articles by Kaplan, G.

 Previous Article  |  Next Article 

Infection and Immunity, April 2002, p. 2100-2107, Vol. 70, No. 4
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.4.2100-2107.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Mycobacterial Antigens Exacerbate Disease Manifestations in Mycobacterium tuberculosis-Infected Mice

Andre L. Moreira,1 Liana Tsenova,2 Melles Haile Aman,3 Linda-Gail Bekker,4 Sherry Freeman,2 Bande Mangaliso,2 Ulf Schröder,3 Jaishree Jagirdar,1 William N. Rom,5 Michael G. Tovey,6 Victoria H. Freedman,2 and Gilla Kaplan2*

Department of Pathology,1 Division of Pulmonary & Critical Care Medicine, New York University School of Medicine,,5 Laboratory of Cellular Physiology & Immunology, The Rockefeller University New York, New York,2 Swedish Institute for Infectious Disease Control, Stockholm, Sweden,3 Infectious Disease Clinical Research Unit, UCT Lung Institute, Cape Town, South Africa,4 Laboratory of Viral Oncology, CNRS, Villejuif, France6

Received 2 August 2001/ Returned for modification 22 October 2001/ Accepted 7 January 2002

To control tuberculosis worldwide, the burden of adult pulmonary disease must be reduced. Although widely used, Mycobacterium bovis BCG vaccination given at birth does not protect against adult pulmonary disease. Therefore, postexposure vaccination of adults with mycobacterial antigens is being considered. We examined the effect of various mycobacterial antigens on mice with prior M. tuberculosis infection. Subcutaneous administration of live or heat-treated BCG with or without lipid adjuvants to infected mice induced increased antigen-specific T-cell proliferation but did not reduce the bacterial load in the lungs and caused larger lung granulomas. Similarly, additional mycobacterial antigen delivered directly to the lungs by aerosol infection with viable M. tuberculosis mixed with heat-killed Mycobacterium tuberculosis (1:1) also did not reduce the bacillary load but caused increased expression of tumor necrosis factor alpha (TNF-{alpha}) and interleukin 6 (IL-6), which was associated with larger granulomas in the lungs. When M. tuberculosis-infected mice were treated with recombinant BCG that secreted cytokines shown to reduce disease in a preinfection vaccine model, the BCG secreting TNF-{alpha}, and to a lesser extent, IL-2 and gamma interferon (IFN-{gamma}), caused a significant increase in granuloma size in the lungs. Moreover, treatment of M. tuberculosis-infected mice with recombinant murine TNF-{alpha} resulted in increased inflammation in the lungs and accelerated mortality without affecting the bacillary load. Taken together, these studies suggest that administration of mycobacterial antigens to mice with prior M. tuberculosis infection leads to immune activation that may exacerbate lung pathology via TNF-{alpha}-induced inflammation without reducing the bacillary load.


* Corresponding author. Mailing address: Laboratory of Cellular Physiology & Immunology, The Rockefeller University, 1230 York Ave., New York, NY 10021. Phone: (212) 327-8375. Fax: (212) 327-8376. E-mail: kaplang{at}rockvax.rockefeller.edu.

Editor: S. H. E. Kaufmann


Infection and Immunity, April 2002, p. 2100-2107, Vol. 70, No. 4
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.4.2100-2107.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2002 by the American Society for Microbiology. All rights reserved.